Literature DB >> 15479393

Clinical diagnosis of von Willebrand disease.

A B Federici1.   

Abstract

von Willebrand disease (VWD) is the most frequent inherited bleeding disorder and is caused by quantitative (Types 1 and 3) or qualitative (Type 2) defects of von Willebrand factor (VWF). VWD is inherited by autosomal dominant or recessive pattern, but women with milder VWD forms seem to be more symptomatic than men. Mild VWD forms are both under- and misdiagnosed. The clinical expression of VWD is usually mild in Type 1, increasing in severity in Types 2 and 3. Mucocutaneous bleeding (epistaxis, menorrhagia) is a typical manifestation of the disease, and bleeding after dental extraction is the most frequent postoperative bleeding type. Because FVIII levels are usually only slightly reduced in most VWD types, spontaneous haemarthroses or haematomas are rare in VWD Types 1, 2A and 2B, whereas in Type 3 the severity of bleeding may resemble haemophilia. In Type 1 VWD, bleeding after delivery is rare because FVIII/VWF levels become normal at the end of pregnancy. Post-operative bleeding may not occur in Type 1 VWD patients, but in Type 3 VWD, prophylaxis is always required. Only a few retrospective studies on clinical diagnosis of VWD are available. In the 1234 cases enrolled by an Italian retrospective study, diagnosis of Types 1, 2 and 3 VWD occurred in young adults (83%), mainly in women (57%). Mucosal bleeding (64%) was more frequent than haematomas or haemarthrosis (15%), and 63% of patients did not require transfusions. In a more recent Italian prospective study (815/1234 cases observed for 1 year in 6/16 Italian centres), only 147 (18%) VWD patients showed bleeding episodes (n = 318) and minor or major surgeries (n = 87).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15479393     DOI: 10.1111/j.1365-2516.2004.00991.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  15 in total

1.  Generation and optimization of the self-administered bleeding assessment tool and its validation as a screening test for von Willebrand disease.

Authors:  M Deforest; J Grabell; S Albert; J Young; A Tuttle; W M Hopman; P D James
Journal:  Haemophilia       Date:  2015-07-14       Impact factor: 4.287

Review 2.  Microparticle analysis in disorders of hemostasis and thrombosis.

Authors:  Micah J Mooberry; Nigel S Key
Journal:  Cytometry A       Date:  2015-02-20       Impact factor: 4.355

Review 3.  The evolution and value of bleeding assessment tools.

Authors:  Natalia Rydz; Paula D James
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824

4.  In vivo gene transfer strategies to achieve partial correction of von Willebrand disease.

Authors:  Lan Wang; Jonathan B Rosenberg; Bishnu P De; Barbara Ferris; Rui Wang; Stefano Rivella; Stephen M Kaminsky; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2012-06-25       Impact factor: 5.695

5.  Pregnancy and delivery in women with von Willebrand's disease and different von Willebrand factor mutations.

Authors:  Giancarlo Castaman; Alberto Tosetto; Francesco Rodeghiero
Journal:  Haematologica       Date:  2009-11-30       Impact factor: 9.941

Review 6.  Prophylaxis of bleeding episodes in patients with von Willebrand's disease.

Authors:  Augusto B Federici
Journal:  Blood Transfus       Date:  2008-09       Impact factor: 3.443

7.  Bleeding from gastrointestinal angioectasias is not related to bleeding disorders - a case control study.

Authors:  Charlotte M Höög; Olle Broström; Tomas L Lindahl; Andreas Hillarp; Gerd Lärfars; Urban Sjöqvist
Journal:  BMC Gastroenterol       Date:  2010-09-28       Impact factor: 3.067

8.  Treatment of patients with von Willebrand disease.

Authors:  Emma Tuohy; Emma Litt; Raza Alikhan
Journal:  J Blood Med       Date:  2011-04-20

9.  An Integrated Approach to von Willebrand Disease and Surgical Myocardial Revascularization.

Authors:  Federica Jiritano; Lucia Cristodoro; Egidio Bevacqua; Emanuele Malta; Pasquale Mastroroberto
Journal:  Thorac Cardiovasc Surg Rep       Date:  2015-09-18

10.  The management of patients with congenital von Willebrand disease during surgery or other invasive procedures: focus on antihemophilic factor/von Willebrand factor complex.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  Biologics       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.